menu ☰
menu ˟

[Correspondence] HPV vaccination in China needs to be more cost-effective

14 Oct 2017

Almost all cases of cervical cancer are caused by human papillomavirus (HPV). China accounts for about a third of the global burden of cervical cancer, with about 98 900 new cases of cervical cancer in China in 2015.1 After 10 years of the HPV vaccine being available in developed countries, HPV vaccines were finally approved in mainland China in 2016. On July 31, 2017, it was announced that HPV vaccines will gradually be made available in community health centres across 17 provinces.2

Click here to view the full article which appeared in The Lancet